Press Room

News / Oct 23, 2018

Hovione New Jersey hosts 2018 PPAR Conference

The Pharmaceutical Process Analytics Roundtable (PPAR) Annual Event at Hovione New Jersey

New Jersey hosts 2018 PPAR Conference | Hovione

During October 15th to 17th, Hovione New Jersey hosted the Pharmaceutical Process Analytics Roundtable (PPAR) annual event. PPAR is a meeting/gathering of PAT practioneers in the Pharma industry that happens once a year where several PAT related topics are discussed (e.g.: regulatory aspects, technology novelties, people & organization, etc.).

Continuous Manufacturing have become a major topic as it makes intense use of PAT for process control and release of product.

Participants for this year event came from Pfizer, Merck, Janssen, BMS, Eli Lilly, AbbVie, Biogen, Amgen, GSK, Sanofi, Vertex, and Genentech. Nuno Matos and Savitha Panikar were the Hovione participants.

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025